Michael Gelband’s GoHealth GOCO Stock Holding History

Michael Gelband’s Portfolio GOCO Stock Details GOCO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-5,933	Closed	-$105K	–	2123
2022 Q1	$105K	Buy	+5,933	New	+$185K	﹤0.01%	2001
2021 Q4	–	Sell	-2,544	Closed	-$192K	–	2328
2021 Q3	$192K	Buy	2,544 +1,070	+73%	+$113K	﹤0.01%	1796
2021 Q2	$248K	Buy	+1,474	New	+$258K	﹤0.01%	1855
2021 Q1	–	Sell	-1,401	Closed	-$287K	–	2288
2020 Q4	$287K	Sell	1,401 -632	-31%	-$117K	﹤0.01%	1563
2020 Q3	$397K	Buy	+2,033	New	+$490K	0.01%	1142

Other funds holding GOCO

Centerbridge Partners New York $38.1M AUM 9.24% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

BOCH

Blue Owl Capital Holdings New York $665M AUM 95.48% 1-Year Est. Return

GCM

Glendon Capital Management Santa Monica, California $773M AUM 8.9% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Michael Gelband's GOCO Position: Q2 2022 in Review

Michael Gelband sold out of GoHealth (GOCO) in Q2 2022, closing a stake of 5,933 shares — an estimated $105K sold.

Michael Gelband first reported a position in GOCO in Q3 2020 and held it in 5 quarters. The position peaked at $397K in Q3 2020. 77 funds tracked by Wall St. Rank hold GOCO as of Q2 2022.

Michael Gelband reported no remaining GoHealth position as of Q2 2022 after selling out during the quarter.
Michael Gelband sold 5,933 GoHealth shares in Q2 2022, an estimated $105K.
Michael Gelband first reported a position in GoHealth in Q3 2020 and held it in 5 quarters.
Michael Gelband's GoHealth position peaked at $397K in Q3 2020.
77 funds tracked by Wall St. Rank held GoHealth as of Q2 2022.

Based on ExodusPoint Capital Management's 13F filing for Q2 2022, filed 22 Aug 2022.